CraniUS Therapeutics
CompanyUnited States
CraniUS Therapeutics develops one asset, approved (NeuroPASS in cranial drug delivery). Mostly device; based in the United States.
- 1
- Asset
- Furthest stage
- Approved
- 0
- Trials
- 0
- Signals
Pipeline
1Implantable cranial device architecture for delivering drugs to the brain
Approved, Device, cranial drug delivery
Full company profiles: pipeline, trials, funding and people.